Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3).

MLA

Lin, Wei, et al. “Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3).” Molecular Cell, vol. 70, no. 1, Apr. 2018, p. 60. EBSCOhost, https://doi.org/10.1016/j.molcel.2018.02.026.

APA

Lin, W., Das, K., Degen, D., Mazumder, A., Duchi, D., Wang, D., Ebright, Y. W., Ebright, R. Y., Sineva, E., Gigliotti, M., Srivastava, A., Mandal, S., Jiang, Y., Liu, Y., Yin, R., Zhang, Z., Eng, E. T., Thomas, D., Donadio, S., … Ebright, R. H. (2018). Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3). Molecular Cell, 70(1), 60. https://doi.org/10.1016/j.molcel.2018.02.026

Chicago

Lin, Wei, Kalyan Das, David Degen, Abhishek Mazumder, Diego Duchi, Dongye Wang, Yon W Ebright, et al. 2018. “Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3).” Molecular Cell 70 (1): 60. doi:10.1016/j.molcel.2018.02.026.